Anthropic / Claude

Investors and analysts told the FT that Anthropic's planned 2027 IPO faces a revenue sustainability problem. Its annualized revenue is about $5 billion, with over 70% coming from fewer than 10 large clients. API revenue has low switching costs, so if rival models catch up on performance, big customers can renegotiate or leave. The article does not disclose a specific IPO valuation target, but notes this revenue concentration will make public-market investors cautious.

Anthropic pushed its IPO from October to November, aiming to show Q3 financials first. The target valuation is around $2 trillion, with a raise of up to $100 billion—both would top SpaceX's record. The company expects annualized revenue above $110 billion by end of 2026. The delay was decided before a former researcher's public warning about AI speed, but investors will still ask how a slower model rollout could hit financials. Existing backers think the impact is limited since current models already generate strong revenue. Meanwhile, OpenAI won't go public before 2027 and is in early talks for a new round that could value it above $1.2 trillion; some Anthropic investors worry that could weaken demand for Anthropic's offering.

Anthropic's test-impact-analysis service saw 25× load growth in six months. Three patches bought 70 days, 29 days, then less than a day of stability. One engineer rewrote it in three weeks—a task the author estimates would have taken a quarter a year ago. The rewrite cost dropped while the hidden cost of patching rose, shifting the break-even point earlier. The post does not disclose the new system's exact running cost, defect rates, or production incident data.

Anthropic confirmed to TechCrunch it operates a wet lab in the Bay Area where its AI models can run physical biology experiments. Eric Kauderer-Abrams, head of life sciences, told Reuters that real lab work remains the final test for biology, and the company does both in-house research and external partnerships. The news follows Anthropic's roughly $400M acquisition of AI biotech startup Coefficient Bio in April.

Anthropic is bringing third-party safety evaluators in-house, starting with Accenture. Staff from Accenture’s AI unit Faculty will red-team models, run alignment assessments, and test safeguards on site. Both sides expect to invest at least $1 billion over five years. Accenture shares jumped 8% after hours. The post doesn’t disclose headcount, start date, or whether evaluation results will be public.

Anthropic is embedding Accenture evaluators inside its own teams to stress-test frontier models for safety before release. The evaluators will probe for vulnerabilities, jailbreaks, and misuse risks. Accenture will also help enterprise clients build their own AI safety testing workflows using Anthropic's methodology. The post does not disclose deal value, headcount, or start date.

The New York Times reports Anthropic's annualized revenue will exceed $100 billion in 2026, ahead of its November IPO. That's a run-rate figure, not full-year actual revenue — worth discounting. The post doesn't disclose profit, cost structure, or how much comes from API vs. enterprise licensing. Only the headline number is available; wait for the S-1 filing to judge the quality of that revenue.

Anthropic is embedding independent evaluators inside the company with employee-level access to training, safety decisions, and blind spots. Accenture's AI unit Faculty will handle red-teaming, alignment assessments, and safeguard testing. Each side expects to invest at least $1B over five years. No industry standards exist yet, so Anthropic is funding Accenture directly while also talking to METR and other nonprofits about alternative funding. The partnership is non-exclusive—Anthropic will name more evaluators soon, and Accenture will work with other AI developers.

A week after an Anthropic researcher's doomsday warning, CEO Dario Amodei outlined a safety plan relying on independent evaluators and coordination among labs in democratic countries. Nvidia's Jensen Huang has already pushed back. The video runs 34 minutes, but the article body only provides the headline and a short lede—no details on evaluation criteria, triggers, or timeline.

A three-person team hacked into OpenAI using a corrupted image file and forum software, with Anthropic's Claude assisting in vulnerability analysis and attack planning. The post doesn't disclose what data was accessed, whether OpenAI has patched the flaw, or the vulnerability specifics.

A three-person team at Hacktron AI used Anthropic's Claude Opus 5 to automate an attack that took over OpenAI employee accounts and accessed an internal code repository. They reported the flaws through OpenAI's bug bounty program and received $6,500. The post doesn't detail the full exploit chain or how long the attack took, but confirms it involved chaining multiple steps. The twist: one company's model was used to break into another, and both sides acknowledged it.

Before auditing the Miden zkVM, Trail of Bits spent six months having AI agents build an LSP server, a decompiler, a static analysis engine, and a Lean formal model from scratch. These tools found real bugs, including an unvalidated input that let a malicious prover forge Falcon signatures and steal funds. The Lean work produced 95 machine-checked correctness proofs. The post mentions Claude built the LSP prototype but doesn't name the specific models used for other tools.

Anthropic CEO Dario Amodei and OpenAI CEO Sam Altman both recently argued publicly for slowing AI progress. Former Anthropic researcher Jacob Coxon left the company saying neither it nor OpenAI is acting responsibly. The article zooms in on one risk: AI-designed bioweapons. In 2022, researchers used their own molecule generator to produce 40,000 potential chemical warfare agents in under six hours, some more toxic than known nerve agents. Stanford's David Magnus called that finding scary, and things have only escalated since. Today's LLMs can answer questions across all scientific domains; Dunja Sabra at the University of Hamburg says they effectively encode the knowledge of almost every scientist who ever lived, and can provide video training on experiments. Combine that with cheaper gene editing and the DIY-bio movement, and Sabra's assessment is that a determined person would likely succeed eventually. Existing safeguards—DNA screening by synthesis companies, red-teaming and blue-teaming of risky research, and safety tweaks by AI companies—are none of them ironclad.

WSJ reports three researchers used Claude Opus 5 to chain a Discourse vulnerability into access to OpenAI employee auth tokens. Some forum tokens also worked on ChatGPT and reached OpenAI's GitHub services. The post doesn't spell out how the bug was exploited or whether OpenAI has patched it.

Kyle Chan argues in the NYT that the US and China worry about fundamentally different AI risks. US labs focus on recursive self-improvement and existential threats; Chinese policymakers see that takeoff as distant and instead fear deepfakes, political dissent, and social instability. Recent cases—OpenClaw data leak warnings, Mythos’s cyber offense capabilities, and an AI tool cracking WeChat accounts—are pushing Beijing to also take cyber and runaway AI risks more seriously. Chan suggests both sides start by acknowledging each other’s risk perceptions before jumping to arms-control talks.

Anthropic disclosed that Claude now handles 26% of its R&D work, measured by code commits rather than headcount or hours. The company says the goal isn't layoffs but shifting engineers toward higher-level system design and safety alignment. I'd discount the number a bit—it's self-reported with no third-party audit, and the post doesn't spell out what counts as R&D work. Even if you halve it, a leading model lab eating over 10% of its own R&D with its own model is the real signal here.

Anthropic published a measurement framework and an internal snapshot to give the public visibility into the pace of frontier AI development. The headline number: Claude now leads 26% of Anthropic's AI R&D tasks, up from under 1% in February 2026. Two other metrics track oversight of AI agents and compute allocation. Anthropic plans to embed independent third-party evaluators to verify the data, but cross-lab comparison still lacks a common methodology.

Dario Amodei published a nearly 4,000-word essay calling for a globally coordinated AI slowdown, with Sam Altman and Elon Musk backing the idea. Critics argue the safety push from top labs looks more like an attempt to lock in their lead than to address real risks. The piece maps both sides but doesn't settle the question.

Anthropic's Dario Amodei proposed 'pacing the frontier' of AI development. Sam Altman and Elon Musk echoed the call; Google and Microsoft paid lip service. The Verge flags suspect motives—this could be a cartel move, not a safety pact. Meta opposes any slowdown. The post does not disclose concrete timelines or technical thresholds, only public statements.

Anthropic overhauled Claude's Projects: it's no longer a folder of chats, but a hosted project space that supports multiple parallel conversation threads with cross-thread context. You can group related conversations into one Project, and Claude remembers context across threads. Team plans get shared projects with permission controls. The post doesn't spell out free-tier project limits or max threads per project.